Recently, acetylcholinesterase inhibitors (AChEIs), primarily Donepezil and Rivastigmine, which are drugs used to treat Alzheimer's disease (AD), have been shown to have a beneficial effect on bone health (32). Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.